Concepts (241)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Growth Disorders | 6 | 2023 | 635 | 1.720 |
Why?
|
Tuberculosis, Multidrug-Resistant | 7 | 2022 | 941 | 1.170 |
Why?
|
Family Characteristics | 3 | 2020 | 1002 | 0.940 |
Why?
|
Child Nutrition Disorders | 3 | 2021 | 140 | 0.930 |
Why?
|
Malnutrition | 3 | 2020 | 632 | 0.900 |
Why?
|
Rwanda | 11 | 2023 | 671 | 0.820 |
Why?
|
Madagascar | 11 | 2023 | 111 | 0.810 |
Why?
|
Child Development | 5 | 2023 | 2329 | 0.780 |
Why?
|
Lost to Follow-Up | 3 | 2020 | 124 | 0.760 |
Why?
|
Rural Health Services | 6 | 2019 | 393 | 0.730 |
Why?
|
Rural Population | 16 | 2023 | 2321 | 0.720 |
Why?
|
Child, Orphaned | 1 | 2021 | 55 | 0.710 |
Why?
|
Antitubercular Agents | 8 | 2022 | 1380 | 0.700 |
Why?
|
Parturition | 1 | 2023 | 454 | 0.650 |
Why?
|
Tuberculosis, Pulmonary | 3 | 2018 | 836 | 0.630 |
Why?
|
Geographic Information Systems | 1 | 2020 | 283 | 0.610 |
Why?
|
Minority Groups | 1 | 2023 | 1214 | 0.520 |
Why?
|
Patient Dropouts | 2 | 2018 | 411 | 0.520 |
Why?
|
Parenting | 2 | 2021 | 708 | 0.510 |
Why?
|
Developmental Disabilities | 2 | 2020 | 1518 | 0.460 |
Why?
|
Language | 1 | 2023 | 1550 | 0.450 |
Why?
|
Russia | 4 | 2018 | 383 | 0.450 |
Why?
|
Disease Transmission, Infectious | 1 | 2018 | 560 | 0.410 |
Why?
|
Mycobacterium tuberculosis | 6 | 2016 | 1911 | 0.390 |
Why?
|
HIV Infections | 7 | 2022 | 17542 | 0.390 |
Why?
|
Communicable Disease Control | 1 | 2018 | 856 | 0.380 |
Why?
|
Infant | 20 | 2023 | 36485 | 0.360 |
Why?
|
Health Services Research | 1 | 2018 | 1815 | 0.360 |
Why?
|
Guatemala | 5 | 2023 | 161 | 0.350 |
Why?
|
Child, Preschool | 21 | 2023 | 42606 | 0.330 |
Why?
|
Ebolavirus | 3 | 2016 | 250 | 0.320 |
Why?
|
Tuberculosis | 5 | 2012 | 2011 | 0.320 |
Why?
|
Sampling Studies | 2 | 2020 | 614 | 0.300 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2020 | 2038 | 0.300 |
Why?
|
Sputum | 1 | 2010 | 514 | 0.290 |
Why?
|
Hemorrhagic Fever, Ebola | 3 | 2016 | 424 | 0.270 |
Why?
|
Alcoholism | 1 | 2016 | 1980 | 0.240 |
Why?
|
Maternal Health Services | 2 | 2020 | 472 | 0.230 |
Why?
|
Socioeconomic Factors | 5 | 2023 | 7848 | 0.220 |
Why?
|
Infant, Newborn | 11 | 2021 | 26396 | 0.220 |
Why?
|
Child | 22 | 2023 | 80771 | 0.220 |
Why?
|
Health Status | 1 | 2017 | 4091 | 0.220 |
Why?
|
Mentors | 2 | 2020 | 672 | 0.220 |
Why?
|
Aflatoxins | 1 | 2023 | 12 | 0.220 |
Why?
|
Urban Population | 2 | 2010 | 2044 | 0.210 |
Why?
|
Bacterial Typing Techniques | 2 | 2002 | 263 | 0.210 |
Why?
|
Adolescent | 18 | 2022 | 89046 | 0.200 |
Why?
|
Alcohol Drinking | 2 | 2012 | 4045 | 0.200 |
Why?
|
Diarrhea | 2 | 2021 | 1319 | 0.200 |
Why?
|
Capacity Building | 2 | 2021 | 265 | 0.190 |
Why?
|
Young Adult | 14 | 2022 | 59980 | 0.180 |
Why?
|
Humans | 52 | 2023 | 767040 | 0.180 |
Why?
|
Operations Research | 1 | 2020 | 22 | 0.180 |
Why?
|
Peru | 2 | 2021 | 888 | 0.180 |
Why?
|
Public Health Practice | 1 | 2002 | 220 | 0.170 |
Why?
|
Quality Improvement | 3 | 2021 | 3854 | 0.170 |
Why?
|
Female | 34 | 2023 | 396660 | 0.170 |
Why?
|
Adult | 26 | 2023 | 223317 | 0.160 |
Why?
|
Patient Acceptance of Health Care | 4 | 2019 | 3232 | 0.160 |
Why?
|
Wasting Syndrome | 1 | 2019 | 96 | 0.160 |
Why?
|
Cross-Sectional Studies | 6 | 2023 | 26325 | 0.160 |
Why?
|
Clone Cells | 1 | 2002 | 1669 | 0.160 |
Why?
|
Follow-Up Studies | 6 | 2020 | 39317 | 0.160 |
Why?
|
Health Surveys | 2 | 2020 | 4056 | 0.160 |
Why?
|
Infant, Low Birth Weight | 2 | 2020 | 871 | 0.150 |
Why?
|
Home Childbirth | 1 | 2018 | 55 | 0.150 |
Why?
|
Male | 31 | 2023 | 364203 | 0.150 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2020 | 392 | 0.150 |
Why?
|
Education, Nursing, Continuing | 1 | 2017 | 69 | 0.140 |
Why?
|
Maternal Mortality | 2 | 2018 | 310 | 0.140 |
Why?
|
Midwifery | 1 | 2018 | 131 | 0.130 |
Why?
|
Fees and Charges | 1 | 2017 | 189 | 0.130 |
Why?
|
Disease Outbreaks | 2 | 2002 | 1761 | 0.130 |
Why?
|
Uganda | 1 | 2021 | 1353 | 0.130 |
Why?
|
Nucleoproteins | 1 | 2016 | 110 | 0.130 |
Why?
|
Perinatal Care | 1 | 2018 | 244 | 0.130 |
Why?
|
Retrospective Studies | 10 | 2023 | 81659 | 0.130 |
Why?
|
Logistic Models | 5 | 2019 | 13284 | 0.120 |
Why?
|
Mass Screening | 2 | 2010 | 5456 | 0.120 |
Why?
|
Middle Aged | 18 | 2020 | 223233 | 0.120 |
Why?
|
Child Mortality | 1 | 2017 | 204 | 0.120 |
Why?
|
Unsafe Sex | 1 | 2016 | 239 | 0.110 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2015 | 238 | 0.110 |
Why?
|
Child Health Services | 1 | 2019 | 645 | 0.110 |
Why?
|
Anthropometry | 1 | 2018 | 1345 | 0.110 |
Why?
|
Infant, Premature | 2 | 2020 | 2125 | 0.110 |
Why?
|
RNA, Viral | 3 | 2016 | 2867 | 0.100 |
Why?
|
Lesotho | 3 | 2022 | 76 | 0.100 |
Why?
|
Men's Health | 1 | 2012 | 75 | 0.100 |
Why?
|
Feasibility Studies | 2 | 2020 | 5311 | 0.100 |
Why?
|
Health Services | 1 | 2017 | 755 | 0.100 |
Why?
|
Health Facilities | 1 | 2016 | 578 | 0.090 |
Why?
|
Body Height | 1 | 2018 | 1565 | 0.090 |
Why?
|
Seroepidemiologic Studies | 2 | 2023 | 404 | 0.090 |
Why?
|
Cluster Analysis | 3 | 2010 | 2721 | 0.090 |
Why?
|
Antigens, Viral | 1 | 2015 | 994 | 0.090 |
Why?
|
Malaria | 1 | 2021 | 1246 | 0.090 |
Why?
|
Continuity of Patient Care | 1 | 2018 | 1078 | 0.090 |
Why?
|
Poverty | 3 | 2021 | 2719 | 0.090 |
Why?
|
Epidemics | 1 | 2016 | 516 | 0.090 |
Why?
|
Family | 1 | 2021 | 3210 | 0.090 |
Why?
|
Risk-Taking | 1 | 2016 | 1023 | 0.090 |
Why?
|
Mothers | 1 | 2020 | 2209 | 0.080 |
Why?
|
Point-of-Care Systems | 2 | 2016 | 1217 | 0.080 |
Why?
|
Attitude to Health | 2 | 2016 | 2023 | 0.080 |
Why?
|
Prevalence | 3 | 2022 | 15851 | 0.080 |
Why?
|
Directly Observed Therapy | 1 | 2010 | 139 | 0.080 |
Why?
|
Brazil | 2 | 2010 | 1250 | 0.080 |
Why?
|
Primary Health Care | 3 | 2022 | 4746 | 0.080 |
Why?
|
Respiratory Tract Infections | 1 | 2017 | 1009 | 0.080 |
Why?
|
Laboratories | 2 | 2002 | 463 | 0.080 |
Why?
|
Risk Factors | 7 | 2022 | 74886 | 0.080 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 4572 | 0.080 |
Why?
|
Prisoners | 1 | 2012 | 315 | 0.080 |
Why?
|
Glycoproteins | 1 | 2016 | 2200 | 0.080 |
Why?
|
Decision Support Techniques | 1 | 2018 | 2006 | 0.070 |
Why?
|
Medical Oncology | 1 | 2020 | 2341 | 0.070 |
Why?
|
Multivariate Analysis | 2 | 2019 | 12069 | 0.070 |
Why?
|
Pregnancy | 4 | 2023 | 30238 | 0.070 |
Why?
|
Nurses | 1 | 2017 | 2501 | 0.070 |
Why?
|
Pilot Projects | 1 | 2021 | 8732 | 0.070 |
Why?
|
Contact Tracing | 3 | 2010 | 274 | 0.070 |
Why?
|
Aged | 12 | 2023 | 171319 | 0.070 |
Why?
|
Diabetes Mellitus | 2 | 2022 | 5886 | 0.070 |
Why?
|
Income | 1 | 2015 | 1877 | 0.070 |
Why?
|
Health Services Accessibility | 3 | 2021 | 5519 | 0.070 |
Why?
|
Developing Countries | 2 | 2017 | 2911 | 0.070 |
Why?
|
Hospitals, District | 2 | 2020 | 114 | 0.070 |
Why?
|
Mental Health | 1 | 2020 | 3272 | 0.060 |
Why?
|
Sierra Leone | 2 | 2016 | 171 | 0.060 |
Why?
|
Hypertension | 2 | 2022 | 8615 | 0.060 |
Why?
|
Diagnostic Errors | 2 | 2002 | 1278 | 0.060 |
Why?
|
Insurance, Health | 1 | 2017 | 2519 | 0.060 |
Why?
|
Hospitals | 1 | 2018 | 3883 | 0.060 |
Why?
|
HIV | 1 | 2012 | 1591 | 0.060 |
Why?
|
Polymorphism, Restriction Fragment Length | 2 | 2002 | 766 | 0.060 |
Why?
|
Equipment Contamination | 2 | 2002 | 183 | 0.060 |
Why?
|
Program Evaluation | 1 | 2012 | 2505 | 0.060 |
Why?
|
Aged, 80 and over | 5 | 2018 | 59548 | 0.060 |
Why?
|
Cross-Over Studies | 1 | 2010 | 2105 | 0.060 |
Why?
|
Incidence | 4 | 2021 | 21526 | 0.050 |
Why?
|
Aflatoxin B1 | 1 | 2023 | 17 | 0.050 |
Why?
|
Streptomycin | 1 | 2002 | 69 | 0.050 |
Why?
|
Zea mays | 1 | 2023 | 109 | 0.050 |
Why?
|
Antibiotics, Antitubercular | 1 | 2002 | 100 | 0.050 |
Why?
|
Bioreactors | 1 | 2023 | 245 | 0.050 |
Why?
|
Treatment Outcome | 5 | 2022 | 65295 | 0.050 |
Why?
|
Treatment Failure | 2 | 2018 | 2658 | 0.050 |
Why?
|
Isoniazid | 1 | 2002 | 279 | 0.050 |
Why?
|
Telemedicine | 1 | 2018 | 3110 | 0.040 |
Why?
|
Health Promotion | 1 | 2012 | 2210 | 0.040 |
Why?
|
Rifampin | 1 | 2022 | 350 | 0.040 |
Why?
|
Sentinel Surveillance | 1 | 2002 | 292 | 0.040 |
Why?
|
Nutritional Status | 2 | 2019 | 1628 | 0.040 |
Why?
|
Medication Adherence | 1 | 2012 | 2191 | 0.040 |
Why?
|
Cities | 1 | 2022 | 542 | 0.040 |
Why?
|
Emigration and Immigration | 1 | 2002 | 406 | 0.040 |
Why?
|
Regional Medical Programs | 1 | 2019 | 64 | 0.040 |
Why?
|
Marital Status | 1 | 2020 | 426 | 0.040 |
Why?
|
Capreomycin | 1 | 2018 | 14 | 0.040 |
Why?
|
Cohort Studies | 2 | 2020 | 41718 | 0.040 |
Why?
|
Amikacin | 1 | 2018 | 48 | 0.040 |
Why?
|
Kanamycin | 1 | 2018 | 63 | 0.040 |
Why?
|
Clofazimine | 1 | 2018 | 39 | 0.040 |
Why?
|
Hospitals, Rural | 1 | 2020 | 174 | 0.040 |
Why?
|
Morbidity | 1 | 2023 | 1754 | 0.040 |
Why?
|
Prospective Studies | 2 | 2023 | 54886 | 0.040 |
Why?
|
Cognition | 1 | 2015 | 7059 | 0.040 |
Why?
|
Maternal Age | 1 | 2020 | 804 | 0.040 |
Why?
|
Sanitation | 1 | 2018 | 83 | 0.040 |
Why?
|
Immunization | 1 | 2022 | 1218 | 0.040 |
Why?
|
Carbapenems | 1 | 2018 | 125 | 0.040 |
Why?
|
Genotype | 3 | 2016 | 13035 | 0.040 |
Why?
|
Cardiovascular Diseases | 1 | 2022 | 15645 | 0.030 |
Why?
|
Fluoroquinolones | 1 | 2018 | 307 | 0.030 |
Why?
|
Time Factors | 2 | 2012 | 40154 | 0.030 |
Why?
|
Anti-HIV Agents | 1 | 2012 | 4567 | 0.030 |
Why?
|
Growth | 1 | 2018 | 366 | 0.030 |
Why?
|
Organizations | 1 | 2016 | 172 | 0.030 |
Why?
|
Research Personnel | 1 | 2020 | 589 | 0.030 |
Why?
|
Massachusetts | 3 | 2002 | 8890 | 0.030 |
Why?
|
Smoking | 1 | 2012 | 9081 | 0.030 |
Why?
|
Seasons | 1 | 2021 | 1523 | 0.030 |
Why?
|
India | 1 | 2021 | 2334 | 0.030 |
Why?
|
Respiratory Tract Diseases | 1 | 2020 | 744 | 0.030 |
Why?
|
Heart Failure | 2 | 2020 | 11877 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2020 | 14766 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2017 | 12250 | 0.030 |
Why?
|
Quality of Health Care | 2 | 2019 | 4306 | 0.030 |
Why?
|
Polymerase Chain Reaction | 1 | 2002 | 6067 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2022 | 22254 | 0.030 |
Why?
|
Pandemics | 2 | 2023 | 8736 | 0.030 |
Why?
|
Antibodies, Viral | 1 | 2023 | 3212 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2019 | 2428 | 0.020 |
Why?
|
Immunoassay | 1 | 2015 | 744 | 0.020 |
Why?
|
Birth Weight | 1 | 2019 | 2122 | 0.020 |
Why?
|
Decision Trees | 1 | 2013 | 508 | 0.020 |
Why?
|
Weight Loss | 1 | 2022 | 2716 | 0.020 |
Why?
|
Neoplasms | 1 | 2020 | 22350 | 0.020 |
Why?
|
Linear Models | 1 | 2021 | 5875 | 0.020 |
Why?
|
Checklist | 1 | 2017 | 842 | 0.020 |
Why?
|
Africa South of the Sahara | 1 | 2013 | 751 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2016 | 14672 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2020 | 15925 | 0.020 |
Why?
|
Microbial Sensitivity Tests | 1 | 2016 | 1969 | 0.020 |
Why?
|
Boston | 1 | 2002 | 9360 | 0.020 |
Why?
|
Quality Indicators, Health Care | 1 | 2019 | 1804 | 0.020 |
Why?
|
Vaccination | 1 | 2022 | 3434 | 0.020 |
Why?
|
Health Care Costs | 1 | 2002 | 3239 | 0.020 |
Why?
|
Observer Variation | 1 | 2015 | 2616 | 0.020 |
Why?
|
Culture | 1 | 2012 | 622 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2018 | 6310 | 0.020 |
Why?
|
Odds Ratio | 1 | 2019 | 9660 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2017 | 2232 | 0.020 |
Why?
|
Body Weight | 1 | 2018 | 4627 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3431 | 0.020 |
Why?
|
Recurrence | 1 | 2018 | 8504 | 0.020 |
Why?
|
CD4 Lymphocyte Count | 1 | 2012 | 2586 | 0.020 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2013 | 951 | 0.020 |
Why?
|
Chronic Disease | 1 | 2020 | 9362 | 0.010 |
Why?
|
Emergency Medical Services | 1 | 2016 | 1936 | 0.010 |
Why?
|
Body Mass Index | 1 | 2022 | 13048 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 10393 | 0.010 |
Why?
|
Inflammation | 1 | 2023 | 10869 | 0.010 |
Why?
|
Anti-Retroviral Agents | 1 | 2012 | 1787 | 0.010 |
Why?
|
Health Personnel | 1 | 2016 | 3387 | 0.010 |
Why?
|
DNA Fingerprinting | 1 | 2002 | 114 | 0.010 |
Why?
|
Patient Compliance | 1 | 2012 | 2697 | 0.010 |
Why?
|
Health Behavior | 1 | 2012 | 2650 | 0.010 |
Why?
|
Echocardiography | 1 | 2013 | 5042 | 0.010 |
Why?
|
Molecular Epidemiology | 1 | 2002 | 473 | 0.010 |
Why?
|
Obesity | 1 | 2022 | 13085 | 0.010 |
Why?
|
False Positive Reactions | 1 | 2002 | 959 | 0.010 |
Why?
|
Patient Satisfaction | 1 | 2012 | 3488 | 0.010 |
Why?
|
Age Factors | 1 | 2016 | 18401 | 0.010 |
Why?
|
Sex Factors | 1 | 2012 | 10622 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2016 | 5363 | 0.010 |
Why?
|
Specimen Handling | 1 | 2002 | 706 | 0.010 |
Why?
|
DNA, Bacterial | 1 | 2002 | 1477 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2015 | 20169 | 0.010 |
Why?
|
Prognosis | 1 | 2016 | 29963 | 0.010 |
Why?
|
Concepts
(241)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(42)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_